[go: up one dir, main page]

ZA897549B - Medicament for the treatment of diseases caused by retroviruses - Google Patents

Medicament for the treatment of diseases caused by retroviruses

Info

Publication number
ZA897549B
ZA897549B ZA897549A ZA897549A ZA897549B ZA 897549 B ZA897549 B ZA 897549B ZA 897549 A ZA897549 A ZA 897549A ZA 897549 A ZA897549 A ZA 897549A ZA 897549 B ZA897549 B ZA 897549B
Authority
ZA
South Africa
Prior art keywords
retroviruses
medicament
treatment
diseases caused
diseases
Prior art date
Application number
ZA897549A
Inventor
Peter Raddatz
Raddatz Peter
Claus J Schmitges
J Schmitges Claus
Klaus E Von Der Helm
E Von Der Helm Klaus
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA897549B publication Critical patent/ZA897549B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
ZA897549A 1988-10-05 1989-10-04 Medicament for the treatment of diseases caused by retroviruses ZA897549B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833764A DE3833764A1 (en) 1988-10-05 1988-10-05 MEDICINAL PRODUCTS FOR THE TREATMENT OF RETROVIRUS DISEASES

Publications (1)

Publication Number Publication Date
ZA897549B true ZA897549B (en) 1990-07-25

Family

ID=6364374

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA897549A ZA897549B (en) 1988-10-05 1989-10-04 Medicament for the treatment of diseases caused by retroviruses

Country Status (6)

Country Link
EP (1) EP0369141A1 (en)
JP (1) JPH02145515A (en)
AU (1) AU628392B2 (en)
DE (1) DE3833764A1 (en)
HU (1) HU204709B (en)
ZA (1) ZA897549B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4126485A1 (en) * 1991-08-10 1993-02-11 Bayer Ag TRIFLUOROMETHYL-CONTAINING PSEUDOPEPTIDE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000399A1 (en) * 1988-07-08 1990-01-25 Smithkline Beckman Corporation Retroviral protease binding peptides
IL91307A0 (en) * 1988-08-24 1990-03-19 Merck & Co Inc Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them

Also Published As

Publication number Publication date
EP0369141A1 (en) 1990-05-23
DE3833764A1 (en) 1990-04-12
JPH02145515A (en) 1990-06-05
HU204709B (en) 1992-02-28
HU895215D0 (en) 1990-01-28
HUT51147A (en) 1990-04-28
AU628392B2 (en) 1992-09-17
AU4246189A (en) 1990-04-12

Similar Documents

Publication Publication Date Title
EG18268A (en) Medicament for the treatment of inflammation of the eye
AU597635B2 (en) Treatment of diseases caused by retroviruses
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
HU912266D0 (en) Process for the production of solid medical preparations with controlled portioning of the active agents for oral use
AU4048295A (en) Peptide medicaments for the treatment of disease
ZM3087A1 (en) Treatment of diseases caused by retroviruses
KR900701323A (en) Ophthalmic preparation for the treatment of new glaucoma
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU2806692A (en) Medicament for the treatment of anxiety
NO884176D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMIDINO DERIVATIVES.
IT8721115A0 (en) PHYTO-PREPARATION FOR THE TREATMENT OF SKIN DISEASES.
GB2220352B (en) Medicaments for the treatment of emesis
PT84755A (en) Process for the preparation of a pharmaceutical composition for the treatment of skin diseases
HK41792A (en) Medicaments for the treatment of emesis
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
EP0416604A3 (en) Paf-antagonists for the preparation of a medicament, useful for the treatment of heart diseases, caused by diminished beta-receptor-stimulation
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
ZM7288A1 (en) Treatment of diseases caused by retroviruses
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
IE893198L (en) Treatment for diseases caused by retroviruses
AU1705783A (en) Medicine for the treatment of the neoplazic disease
DE3366025D1 (en) Medicine for the treatment of the neoplazic disease
AU2564188A (en) Agent for the treatment of heart disease
IL100959A0 (en) Use of tetrahydro-thienopyrido-indole derivatives for the preparation of a medicine for the treatment of skin disorders
DK681288A (en) AENOOTROPT THERAPEUTIC MEDICINE